Frisk Schaefer (braceferry3)

Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease after a period of response. Limited data are available on the clinical patterns of acquired resistance (AR) to ICIs. Clinical and radiologic data from 125 NSCLC patients treated with anti-PD-1 or PD-L1 antibodies between 2011 and 2018 at two tertiary academic institutions were retrospectively reviewed. Overall, 63 (50.4%) patients experienced AR after ICI treatment in a median of 10.7 months. Among the 13 patients with a partial response with ICI, 12 (32.4%) had only lymph node progression. selleck Most patients (n = 52, 82.5%) had one or two sites with progression (oligo-progression). The median overall survival (OS) after progression was significantly longer in the extrathoracic group than in the thoracic and liver progression groups (30.2 months [95% confidence interval (CI), 13.4 to not reached (NR)], 11.7 months [95% CI, 9.5-21.1], and 5.4 months [95% CI, 2.6-NR], respectively, P less then 0.001). Patients with oligo-progression had significantly longer OS after AR than did the multi-progression patients (18.9 months [95% CI, 10.6-NR] vs. 8.8 months [95% CI, 5.7-NR], P = 0.04). No significant difference in progression-free survival was observed between the subsequent chemotherapy and the ICI after AR groups (P = 0.723). Patients with AR after ICI treatment had a unique progression pattern with oligo-progression and high rates of progression only in the lymph nodes. Local treatment and/or continuation of ICIs beyond AR might be an effective option.Trees in the upper canopy contribute disproportionately to forest ecosystem productivity. The large, canopy-emergent Bertholletia excelsa also supports a multimillion-dollar commodity crop (Brazil nut), harvested almost exclusively from Amazonian forests. B. excelsa fruit production, however is extremely variable within populations and years, destabilizing local harvester livelihoods and the extractive economy. To understand this variability, data were collected in Acre, Brazil over 10 years at two sites with similar climate and forest types, but different fruit production levels, despite their proximity (~ 30 km). One site consistently produced more fruit, showed less individual- and population-level variability, and had significantly higher soil P and K levels. The strongest predictor of fruit production was crown area. Elevation and sapwood area also significantly impacted fruit production, but effects differed by site. While number of wet days and dry season vapor pressure prior to flowering were significant production predictors, no climatic variables completely captured annual observed variation. Trees on the site with higher available P and K produced nearly three times more fruits, and appeared more resilient to prolonged drought and drier atmospheric conditions. Management activities, such as targeted fertilization, may shield income-dependent harvesters from expected climate changes and production swings, ultimately contributing to conservation of old growth forests where this species thrives.Sex differences in the brain of mammals range from neuroarchitecture through cognition to cellular metabolism. The hippocampus, a structure mostly associated with learning and memory, presents high vulnerability to neurodegeneration and aging. Therefore, we explored basal sex-related differences in the proteome of organotypic hippocampal slice culture, a major in vitro model for studying the cellular and molecular mechanisms related to neurodegenerative disorders. Results suggest a greater prevalence of astrocytic metabolism in females and significant neuronal metabolism in males. The preference for glucose use in glycolysis, pentose phosphate pathway and glycogen metabolism in females and high abundance of mitochondrial respiration subunits in males support this idea. An overall u